Yijia Group Corp. raises $957K via private placement of ~19.1M shares at $0.05 each

VitaNova Life Sciences Corp

Gross proceeds of $957,051; shares sold at $0.05 per share to 10 investors.
Two U.S. accredited investors (Reg D) and eight non-U.S. investors (Reg S) participated.
Shares are unregistered and subject to resale restrictions under the Securities Act.
Offering closed on January 30, 2024; conducted on a rolling basis with no minimum or maximum.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VitaNova Life Sciences Corp entered into Purchase Agreements with ten investors valued at aggregate gross proceeds of $957,051 (effective 2024-01-30).

Action: entry
Agreement: equity purchase
Counterparty: ten investors
Value: aggregate gross proceeds of $957,051
Effective: 2024-01-30

Exact text from the filing

On January 30, 2024, Yijia Group Corp. (the “Company”) entered into ten securities purchase agreements (the “Purchase Agreements”) in connection with its private offering (the “Offering”) of the Company’s unregistered shares of common stock, par value $0.001, with a total of ten (10) investors, consisting of two (2) U.S. accredited investors, as defined under Rule 501 of Regulation D, and eight (8) non-U.S. investors (individually, an “Investor” and collectively, the “Investors”), at a purchase price of $0.05 per share.

View on SEC.gov

154 material agreements filed in the last 30 days. Browse all material agreements →

VitaNova Life Sciences Corp filing history →

Source: SEC EDGAR

accession 0001683168-24-000681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.